Sponsor Pipeline

Joint Stock Company European Medical Centre Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07141732 Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent®… Glioblastoma Recruiting
Disease Areas
Get alerts when Joint Stock Company European Medical Centre's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free